Yazyme Biopharma

What Yazyme Biopharma does

Yazyme Biopharma (雅酶生物), also operating under the brand Epizyme Biotech, is a privately held life sciences research tools manufacturer founded in 2019 and headquartered in Shanghai's Minhang District. The company produces biological research reagents spanning a catalog of over 17,000 products, organized across 11 core categories: antibodies (recombinant monoclonal, polyclonal, flow cytometry, loading controls, tag, and secondary), protein extraction/quantification, protein electrophoresis, Western Blot workflow reagents, protein purification/expression (including IP kits, magnetic beads, cell-free systems), recombinant and natural proteins, cell culture (FBS, media, proliferation/apoptosis assays), ELISA kits (human, rat, mouse), nucleic acid research reagents (qPCR, cloning, extraction), microbial culture media, and electrophoresis imaging equipment. Its core technical capability is recombinant monoclonal and polyclonal antibody production using mammalian cell expression systems, with products affinity-purified and validated across Western Blot, ELISA, immunohistochemistry, immunofluorescence, and flow cytometry applications, with cross-species reactivity against human, mouse, and rat targets.

The company operates a 2,600 m² R&D center and a 4,600 m² production center co-located at its Shanghai headquarters, providing in-house control over product development, manufacturing, and quality assurance. Its go-to-market is a direct-to-customer e-commerce model via epizyme.cn, with no disclosed distributor or third-party channel, supplemented by WeChat-based engagement and a knowledge center for technical content. Revenue mechanics consist of one-time per-unit product sales priced in Chinese Yuan (¥258–¥1,780 per unit across the visible catalog), with conjugated flow cytometry formats (PE, FITC, APC) priced at premiums. The primary customer segment is academic research institutions (universities and research institutes), with pharmaceutical and biotech R&D organizations as a secondary vertical. The company claims over 10,000 research customers and products cited in more than 4,000 SCI publications.

Firmographics list 1–10 employees, which appears inconsistent with the operational footprint of a 7,200 m² dual facility supporting 17,000+ SKUs and 10,000+ customers; this likely reflects incomplete data or a small core FTE count supplemented by contract/outsourced labor. The company has disclosed a single funding round of approximately $5.63 million from Alading in April 2025, has no listed patents, awards, certifications, M&A, partnerships, or executive team on its public-facing materials, and discloses no revenue figures. All stated source IDs supporting this profile are unless otherwise noted.

Name

Yazyme Biopharma

Legal name

上海雅酶生物医药科技有限公司

Website

https://epizyme.cn

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Yazyme Biopharma (雅酶生物/Epizyme Biotech) is a Shanghai-based life sciences research tools manufacturer producing 17,000+ products including recombinant antibodies, ELISA kits, and Western Blot reagents, sold direct-to-customer via e-commerce primarily to academic and pharmaceutical researchers in China.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Antibody reagents
• Western blot kits
• ELISA kits
• Cell culture reagents
• Protein electrophoresis

Headquarters

HQ city

Minhang

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Research Reagent Sales: One-time product sales of antibodies, proteins, assay kits, and laboratory reagents to research customers. Revenue generated through direct product purchases with prices varying by product type, size, and conjugation format.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Yazyme Biopharma manufactures and sells life science research reagents and instruments, with its core offering being antibodies (over 17,000 SKUs of recombinant monoclonal, polyclonal, conjugated, loading control, tag, and secondary antibodies) along with supporting workflow reagents for protein extraction, electrophoresis, Western blotting, protein purification, ELISA, cell culture, and nucleic acid research. The company sells these reagents and electrophoresis imaging equipment directly to research laboratories through its e-commerce website epizyme.cn.

Product overview

Yazyme Biopharma (雅酶生物/Epizyme Biotech) is a Chinese biotechnology company specializing in biological research reagents. The company offers a unified platform of reagents and instruments organized into 11 core product categories covering the entire life science research workflow: Antibodies (over 17,000 products including primary antibodies, secondary antibodies, flow cytometry antibodies, and isotype controls), Protein Extraction and Quantification, Protein Electrophoresis (including stain-free PAGE gels, precast gels, and buffers), Western Blot (transfer, blocking, antibody incubation, and imaging reagents), Protein Purification (immunoprecipitation kits, magnetic beads, cell-free expression systems), Proteins (recombinant and natural), Cell Culture (FBS, media, proliferation assays), ELISA Kits (human, rat, mouse), Nucleic Acid Products (qPCR, cloning, extraction), Microbial Culture (LB media), and Electrophoresis Imaging Equipment (chemiluminescence imagers, electrophoresis systems). The company operates research and development facilities (2,600 m²) and production centers (4,600 m²), serving over 10,000 research customers with products referenced in over 4,000 SCI publications.

Differentiator

Problem solved

Functional benefit

Brands

• CellorLab: Brand for cell culture and related products

Products and services

• Antibodies (抗体) Comprehensive portfolio of primary and secondary antibodies including premium antibodies, flow cytometry antibodies, recombinant monoclonal antibodies, polyclonal antibodies, loading control antibodies, tag antibodies, and secondary antibodies. The catalog contains over 17,000 products targeting proteins across Western Blot, ELISA, Immunohistochemistry, Immunofluorescence, and Flow Cytometry applications.
• Protein Extraction and Quantification (蛋白提取与定量) Reagents and kits for protein extraction and protein quantification, supporting Western blot and other protein analysis workflows.
• Protein Electrophoresis (蛋白电泳) Complete electrophoresis product line including stain-free PAGE gel quick preparation kits, PAGE gel preparation kits, precast gels, protein molecular weight standards, protein loading buffers, electrophoresis buffers, and protein staining solutions.
• Western Blot Reagents (蛋白免疫印迹) Full Western blot workflow products covering transfer and blocking reagents, antibody incubation solutions, chemiluminescent imaging reagents, and complete Western blot kits.
• Protein Purification (蛋白表达纯化与分离) Products for protein expression, purification, and separation including immunoprecipitation kits, immunomagnetic beads, agarose magnetic beads and immuno-gels, protein labeling and purification reagents, magnetic racks, lentivirus packaging systems, common buffers, protein purification enzymes, cell-free protein expression systems, and transfection reagents.
• Proteins (蛋白质) Recombinant and natural proteins for research applications.
• Cell Culture (细胞培养) Cell culture reagents including premium fetal bovine serum (FBS), basic culture media and reagents, cell proliferation and apoptosis assays, cell cycle analysis products, cell stimulants, cell freezing media, antibiotics for contamination prevention, immunofluorescence reagents, and hybridoma screening products. Branded as CellorLab.
• ELISA Kits (ELISA试剂盒) Enzyme-linked immunosorbent assay kits for human, rat, and mouse samples, along with colorimetric substrates.
• Nucleic Acid Products (核酸相关实验) Products for nucleic acid research including qPCR/reverse transcription PCR reagents, molecular cloning tools, nucleic acid extraction kits, nucleic acid electrophoresis reagents, and nucleases.
• Microbial Culture (微生物培养) Ready-to-use LB liquid and plate culture media for microbial cultivation.
• Electrophoresis Imaging Equipment (电泳成像设备与耗材) Electrophoresis and imaging equipment including chemiluminescence imagers, electrophoresis power supplies, vertical and horizontal electrophoresis systems, wet transfer devices, automatic multi-function gel preparation instruments, and instrument accessories.

Quantifiable outcome

• Over 4,000 SCI publications cite use of company products

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators5 records

Expansion highlights5 records

Direct peers

• Cell Signaling Technology: US-headquartered leader in application-validated antibodies and reagents for Western Blot, IHC, IF, flow cytometry and ELISA. Directly comparable as a research-reagent manufacturer with deep catalog, validation data, and academic customer base.
• Abcam (Danaher): Global antibody and reagent supplier with one of the largest research-grade antibody catalogs. Comparable in product breadth, target customer (academic/biotech research labs), and direct sales model.
• Proteintech: Chinese-origin, globally distributed antibody and reagent manufacturer serving academic and biotech researchers. Highly comparable because of overlapping recombinant antibody technology, similar multi-application validation, and shared Chinese manufacturing base.
• GenScript: Major Chinese life-science tools company offering recombinant proteins, antibodies, gene synthesis and cell therapy services. Comparable in Chinese manufacturing footprint and overlapping antibody/reagent product line.
• Santa Cruz Biotechnology: Long-established research antibody and reagent supplier with a very broad catalog across WB, IHC, IF, IP and flow cytometry. Comparable target customer (academic research labs) and product breadth.
• ABclonal: Chinese antibody and reagent producer with polyclonal and recombinant monoclonal offerings. Directly competes with Yazyme in China on recombinant antibody technology and academic customer base.
• Sino Biological: Chinese-origin recombinant protein and antibody manufacturer for research and immunoassay use. Comparable catalog (recombinant proteins + antibodies + ELISA reagents) and customer base.

Broad incumbents

• Bio-Rad Laboratories: Large, diversified life-science tools provider covering electrophoresis, Western Blot, imaging, ELISA kits and reagents. Comparable as a broad-line incumbent with overlapping WB and protein-analysis reagent categories.
• Thermo Fisher Scientific: Largest life-science tools conglomerate offering antibodies, ELISA kits, cell culture, Western Blot reagents and instruments under multiple brands (Invitrogen, Thermo Scientific, Pierce). Comparable as a broad incumbent with overlapping reagent and instrument categories.
• Bio-Techne (Novus Biologicals / R&D Systems): Major reagent supplier of proteins, antibodies, ELISAs and cell-culture tools via R&D Systems and Novus Biologicals. Comparable as a broad-line reagent incumbent with deep academic publication footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yazyme Biopharma